transparent gif
ImmuneSupport.com Home  
Peripheral Neuropathy Associated With Fluoroquinolone Antibiotics
Fibromyalgia & Chronic Fatigue Syndrome Home Page Fibromyalgia & Chronic Fatigue Syndrome Library Fibromyalgia & Chronic Fatigue Syndrome Treatment and Research Email bulletins Fibromyalgia & Chronic Fatigue Syndrome Products Fibromyalgia & Chronic Fatigue Syndrome Community Area Fibromyalgia & Chronic Fatigue Syndrome About Us transparent gif transparent gif
transparent gif
Health Watch Newsletter background The Latest News Articles background The Latest Abstracts background The Latest Drug News background
Search Our Site
 
Home
Fibromyalgia Resources

Chronic Fatigue Syndrome Resources

E-mail Bulletin
Store
Community
About Us

Your Support Funds Research & Advocacy

Peripheral Neuropathy Associated With Fluoroquinolone Antibiotics


ImmuneSupport.com

11-12-2001

Advertisement

Analysis of 45 cases in which fluoroquinolone antibiotics (including 11 cases involving ciprofloxacin) were associated with adverse effects involving the peripheral nervous system. Adverse effects involving other systems occurred in 42 (93%) of these patients: 78% also experienced central nervous system (CNS) symptoms, 73% reported musculoskeletal symptoms and in 18%-42% of cases the cardiovascular and gastrointestinal systems, skin, and special senses were involved.

2 cases were mild (4%), 7 moderate (16%), and 36 severe (80%) with chronic pain and/or significantly limited normal function. Twelve cases (27%) lasted longer than 2 years. These severe, long-term reactions occurred in a generally young and healthy population. 62% had no other medical disorder except the infection that prompted fluoroquinolone therapy.

The cases presented here, as well as previously published articles about the adverse effects of fluoroquinolones, should give physicians pause before using fluoroquinolones unnecessarily.

Patients must be informed that with the development of any musculoskeletal, or peripheral or central nervous system symptoms, fluoroquinolone treatment should be discontinued immediately unless medical circumstances (e.g., severe infection and no alternative treatment) warrant otherwise. Patients sustaining these reactions should not receive fluoroquinolone antibiotics in the future.

  Newsletter SignUp Discuss (0 comments) Email Article Print Page
Related Articles:
Chronic Fatigue Syndrome Name Change: The Case for Neuroendocrine Immune Syndrome
Rating of 3.1
Seasonal symptom variation in patients with chronic fatigue: comparison with major mood disorders
Rating of 3

Every purchase funds research, donations and the community resources provided within our website.

Organic & pure - 100% acacia
RenewLife Clear Fiber

Buffered for easy absorption
Pro-C Complex™ 500mg

Our new proprietary energy NADH
Energy NADH™ 10 mg

Getting your daily supplements has never been easier!
Daily Health ProPack™

At ProHealth we believe in "commerce with compassion."

Weekly Special





[ Be the first to comment on this article ]
DISCUSS THIS ARTICLE  (0 existing comments)
Post a Comment
transparent gif
transparent gif transparent gif transparent gif

Home | Library | Email Bulletins | Store | Community | Affiliates


ProHealth's ImmuneSupport.com- The World's Largest Fibromyalgia & Chronic Fatigue Syndrome Website!
Email US or Call US at 1-800-366-6056
Monday-Friday, 7 a.m.-5 p.m. PST
International Callers can reach us at 001.805.564.3064
Copyright © 2008 ProHealth, Inc.
About us, Affiliates, Careers, Contact us, Privacy, 30-day Money Back Guarantee